Nivolumab-associated Nausea and Vomiting As an Immune Adverse Event
Overview
Authors
Affiliations
Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors.
Magahis P, Corso T, Livingstone P, Tom E, Srivastava A, Postow M J Immunother Cancer. 2024; 12(7).
PMID: 39032941 PMC: 11261704. DOI: 10.1136/jitc-2024-009051.
Zhang Q, Li C, Cao Y, Wang N, Huang L, Shang Z Clin Case Rep. 2024; 12(1):e8411.
PMID: 38235413 PMC: 10792699. DOI: 10.1002/ccr3.8411.
Nivolumab-induced tumour-like gastritis: A case report.
Cijauskaite E, Kazenaite E, Strainiene S, Sadauskaite G, Kurlinkus B World J Clin Cases. 2023; 11(18):4350-4359.
PMID: 37449232 PMC: 10336988. DOI: 10.12998/wjcc.v11.i18.4350.
Liu J, Xue H, Bai S, Wang J, Zhang Y, Liu L Heliyon. 2022; 8(11):e11248.
PMID: 36387537 PMC: 9649979. DOI: 10.1016/j.heliyon.2022.e11248.
Ai Q, Chen W, Li Y, Li G Front Immunol. 2022; 13:840916.
PMID: 35720298 PMC: 9204206. DOI: 10.3389/fimmu.2022.840916.